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Abstract 
The effect of polymer coatings on the pulmonary toxicity of multi-walled carbon nanotubes 
Lindsey M. Bishop 
Nanotechnology is the science of developing and manipulating molecular structures 
smaller than one hundred nanometers in at least one dimension. These structures are collectively 
called engineered nanomaterials. A subgroup of these engineered nanomaterials are multi-walled 
carbon nanotubes (MWCNT). They are of great interest to industry because of their small size, 
large surface area, strength, and conductivity in comparison to materials currently used. Practical 
applications of MWCNT include improvements for water filtration systems, composites, and drug 
delivery. The same properties that make them advantageous for industry may also confer adverse 
health effects. For workers in the U.S. handling CNTs, the process of synthesizing and handling 
the dry powder form has been shown to be the greatest risk for inhalation exposure.  
Companies synthesize or purchase as-produced multi-walled carbon nanotubes (AP-MW), 
apply a polymer coating (PC-MW), then embed the PC-MW into a composite (e.g. thermoplastic 
or fiberglass matrix). The intermediate step of polymer coating the AP-MW is for increased 
dispersion in order to use less material, improve bonding to epoxy matrices for increased strength, 
and better handling to reduce exposure. Workers are potentially exposed at each production stage 
especially from dry powder handling of the AP-MW and PC-MW. Comprehensive toxicological 
data on AP-MW and paired PC-MW remains sparse. The aim of this study was to understand the 
effect of polymer coatings on the toxicity of AP-MW in vivo. Two AP-MW, with different 
characteristics, were chosen for this study. Each AP-MW came from a distinct manufacturer, each 
with the polymer coated version for toxicological analyses.  
All materials used for the in vivo toxicological studies were comprehensively characterized 
(e.g., length, width, surface area, etc.). Male C57BL/6J mice were dosed by oropharyngeal 
aspiration with vehicle (physiologic dosing medium), AP-MW or PC-MW from each company at 
4 µg (workplace relevant) or 40 µg (known to induce pathology) and sacrificed at 4 h, 1, 7, 28 and 
84 d post-exposure. Post-exposure analyses included: bronchoalveolar lactate dehydrogenase 
activity (cytotoxicity), cell influx (inflammation) and inflammatory proteins, and relative mRNA 
expression in pulmonary tissue. Qualitative pathological endpoints such as granuloma formation 
and fibrosis were examined in conjunction with pulmonary biodistribution primarily to address 
differences due to the polymer coating. Both AP-MW induced time- and dose-dependent measures 
of pulmonary cytotoxicity, inflammatory cell influx, and inflammatory proteins that resolved by 
84 d post-exposure. The PC-MW from Company 1 had no additional effect on induced pulmonary 
cytotoxicity, inflammatory cell influx, or inflammatory gene expression and inflammatory protein 
production as compared to the respective AP-MW. However, pulmonary cytotoxicity, 
inflammatory cell and inflammatory protein production were attenuated in the PC-MW exposed 
groups from Company 2 in comparison to the respective AP-MW. Based on qualitative 
observations of AP-MW and PC-MW from Company 1, particles deposited mostly within the 
bronchioles, were generally cleared by 84 d while a small portion was persistent in alveolar 
regions. There was no difference in histopathology with respect to the materials compared from 
Company 1. Similar distribution of particle deposition in lung compartments was observed for AP-
MW and PC-MW exposed groups from Company 2, however a larger fraction deposited into 
alveolar regions. Small granulomas were observed in the bronchioles of AP-MW exposed groups 
from Company 2. In contrast, granuloma formation was absent in the PC-MW exposed groups 
with slightly more particle aggregation. In conclusion, the two polymer coatings studied did not 
increase the pulmonary toxicity compared to the AP-MW. In fact, inflammation and 
histopathology was attenuated in mice exposed to the polymer coating from Company 2. It is 
evident that pulmonary toxicity, from AP-MW to PC-MW, must be carefully considered within 
the occupational setting. 
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2.0 Introduction 
2.1 Nanotechnology and carbon nanotubes 
Nanotechnology is the science of developing and manipulating molecular structures, called 
engineered nanomaterials, which are smaller than one hundred nanometers in at least one 
dimension for use in macroscale products (Donaldson et al., 2006). Within the last two decades, 
nanotechnology has become a major research and manufacturing field for the creation of stronger 
materials, longer-lasting fabrics and scratch resistant plastics for use in industrial and consumer 
sectors. Practical applications for nanotechnology have tremendous potential in consumer based 
products. These include water filtration systems, sunscreens, electronic microprocessors, and 
thermoplastics (Thostenson et al., 2002; Liu et al., 2005; Xiong et al., 2006). The benefits of 
incorporating engineered nanomaterials into composites allow manufacturers to tailor the 
molecular structure of these materials to achieve specific chemical properties for functionally 
distinct products. For example, the final product of an item reinforced with nanomaterials can be 
stronger, more reactive, or improve electrical conductivity (Martins et al., 2013). To date, over 
eight hundred commercial products rely on nanoscale materials and processes. 
The carbon-based engineered nanomaterials are some of the most widely utilized for 
market applications. As their name suggests, carbon nanomaterials are composed of carbon with 
varying metal impurities, as a result of their formation and synthesis. Most carbon nanomaterials 
take the form of spheres or tubes. Spherical carbon nanomaterials are referred to as fullerenes, 
which were discovered by Robert Curl Jr., Harold Kroto and Richard Smalley (Liu et al., 1998). 
These individuals won a Nobel Prize in Chemistry in 1996 for their discovery of fullerenes (Royal 
Swedish Academy of Sciences, 1996). In the same type of process that formed fullerenes, Sumio 
Iijima discovered cylindrical concentric tubes, which today are referred to as multi-walled carbon 
nanotubes (MWCNT). A short time later, Iijima took the information about MWCNT and isolated 
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single walled carbon nanotubes (SWCNT) in the presence of a metal catalyst. SWCNT are hollow 
tubes composed of a single layer of carbon with diameters around one nanometer (Yudasakaet al., 
1997; DeVolder et al., 2013). The formation of SWCNT is favored when the metal nanoparticles-
to-carbon ratio are high, whereas, MWCNT can be formed with minimal amounts of metal catalyst, 
these catalysts act to align the nanotubes for further downstream applications (Zhang et al., 1999). 
However, the metal impurities utilized for the formation of SWCNT and MWCNT are generally 
unfavorable in commercial products (Baughman et al., 2002). For this reason, large batches of 
CNT are sold in purified forms, with metal contaminants removed. Once formed, both SWCNT 
and MWCNT have an incredible propensity to agglomerate. This is due to intrinsic van der Waals 
forces, and high hydrophobicity. Because these materials agglomerate easily, they are often 
incorporated into liquid medium for increased dispersion (Donaldson et al., 2006; Porter et al., 
2008). An increase in dispersion for industrial purposes provides a more homogenous mixture for 
a stronger and durable end product. Without adequate dispersion techniques, an agglomerated 
heterogeneous blend could lead to a fragile product.  
As shown in Figure 1, SWCNT become agglomerated tangles in liquid medium. SWCNT 
appear as very thin fibers having diameters of about one nanometer and being several micrometers 
long, which results in their high aspect ratio (length/diameter) (Donaldson et al., 2006; Ajayan et 
al., 1997). Rarely do SWCNT exist as individual tubes but rather as bundles. From a market 
perspective, SWCNT only make up a small subset of carbon-based nanomaterials (Future Markets 
Inc., January 2016). It is the larger MWCNT that dominate the current CNT market. In contrast to 
SWCNT, MWCNT have additional concentric layers with much larger diameters between five and 
two hundred nanometers (Donaldson et al., 2006; Oberdorster et al., 2016). In addition, the lengths 
of MWCNT can be much longer than that of SWCNT. MWCNT have weaker van der Waals forces 
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and can exist as single tubes and form fewer bundles, especially with increasing diameters as seen 
in Figure 1 (Yu et al., 2000). 
2.2 SWCNT-induced pulmonary effects  
While industry saw the potential for numerous applications, there was uncertainty about 
how CNT would affect biological systems. Initial field studies indicated that inhalation was the 
most likely route of exposure for individuals working with the dry powder form of CNT (Dahm et 
al., 2011). The dry powder exhibit a lower density. Therefore, it aerosolizes with ease and has the 
ability for deposition into the airways within the lungs (Muhlfeld et al., 2012). The pulmonary 
system is a highly branched network of tubules which culminate into a complex web of vascular 
alveoli. These alveoli are specialized for providing a large surface area in the lung for gas exchange 
of oxygen and carbon dioxide. Small inhaled particles, such as CNT, can travel through this 
network and into alveolar regions and may impede the efficiency of gas exchange, whereas larger 
particulates deposit within upper airways of the primary bronchi, and generally are cleared 
(Oberdörster et al., 2005; Simeonova et al., 2009). Normally, in these alveolar regions, particles 
 
Figure 1: Representative transmission electron microscopy pictures of 
SWCNT (left panel) and MWCNT (right panel) preparations in 
dispersion media (Erdely et al., 2009). 
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are blocked from entry into the systemic circulation by a plethora of host defenses. These defense 
mechanisms can range from a protective epithelial cell lining, to resident phagocytic cells, to the 
surfactant layer. Particle exposures are known to induce tissue injury and potentially affect 
pulmonary function (Deng et al., 2005; Bergamaschi et al., 2006; Simeonova et al., 2009). Because 
of their physicochemical characteristics, it was suspected that CNT would have the ability to 
induce pulmonary damage in vivo.  
The initial studies to evaluate the toxicity of CNT were performed using SWCNT (Lam et 
al., 2004; Warheit et al., 2004; Shvedova et al., 2005; Mangum et al., 2006). In 2004, Lam et al., 
intratracheally instilled mice with SWCNT and found that exposure to these materials induced 
dose-dependent epithelioid granulomas, and in some cases interstitial inflammation 7 d post-
exposure. They concluded that if SWCNT reached the lungs, these induced toxicities can be 
considered an occupational health hazard if chronically inhaled (Lam et al., 2004). Shvedova et al. 
(2005) introduced a large bolus dose (10-80 µg) of SWCNT by pharyngeal aspiration in mice. In 
this technique, a dose of material is deposited into both the conducting and respiratory zone of the 
lung, while the animal is under light anesthesia and breathing normally. Following exposure, this 
group described an inflammatory and granulatomas response at sites of SWCNT agglomerate 
deposition in the distal bronchial and proximal alveoli. In addition, exposed mice showed signs of 
interstitial fibrosis 7 days post-exposure in the lung parenchyma, concluding that these nanotubes 
translocated to distal alveolar septa (Shvedova et al., 2005). Most of the scientific community 
agreed that pulmonary exposures to SWCNT induced varying degrees of inflammation, granuloma 
formation and interstitial fibrosis (Lam et al., 2004; Warheit et al., 2004; Shvedova et al., 2005) 
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2.3 SWCNT induces cardiovascular and systemic toxicities 
In addition to SWCNT impacting the pulmonary tissue, a group of researchers studied the 
cardiovascular toxicity and systemic translocation of SWCNT following pulmonary exposure. Li 
et al. (2007) showed that pulmonary toxicity of SWCNT following respiratory exposure could be 
correlated with systemic toxicities. They were able to demonstrate a dose-dependent increase in 
vascular oxidative damage and mitochondrial dysfunction (Li et al., 2007).  Furthermore, they 
found that mice exposed to SWCNT developed aortic mitochondrial DNA damage over 60 days 
post-exposure, lending support that respiratory exposure to SWCNT may exert prolonged adverse 
health effects. Mitochondrial dysfunction has been used as a factor to link a number of 
cardiovascular diseases, including atherosclerosis (Li et al., 2007; Simeonova et al., 2009). With 
the onset and progression of atherosclerosis, inflammatory cells are recruited to sites of insult by 
activated platelets. This in turn recruits leukocytes to the site of damage to clear debris and begin 
repair mechanisms. Pulmonary exposures to SWCNT induced platelet activation, and exacerbated 
atherosclerotic lesion formation, in vivo (Simeonova et al., 2009; Li et al., 2007). Erdely et al. 
(2009) explained that a chronic systemic response to pulmonary exposures of SWCNT can 
exacerbate cardiovascular dysfunction. This group established that respiratory exposure to 
SWCNT caused the development of a unique blood gene and protein signature, which confirmed 
the intricate occurrence of cross-talk between the pulmonary and systemic circulations following 
exposure (Erdely et al., 2009).  Overall, the in vivo experiments detailing the adverse effects of 
pulmonary exposure to SWCNT were vital when assessing the potential health impact on a larger 
scale, such as the workers who may be at risk for inhaling CNT.  
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2.4 MWCNT-induced pulmonary effects  
Over the years, our knowledge of the pulmonary and systemic exposures to SWCNT has 
led scientists to investigate the impact of MWCNT on pulmonary toxicity, seeing that this material 
dominates the current consumer market. In 2008, researchers at the University of Edinburgh 
described inflammation and formation of granulomas, in the mesothelial lining of the chest cavity 
in mice following intrapleural instillation of MWCNT (Poland et al., 2008). In addition, Muller et 
al. (2005) administered a bolus dose of MWCNT (unprocessed and ground material) to Sprague-
Dawley rat lungs by intratracheal instillation. This group reported that 60 days post-exposure, 
pulmonary tissue had significant increases in inflammation, granulomas and fibrosis compared to 
control. In those exposures, the ground form of  MWCNT were more dispersed in alveolar regions 
and induction of granulomas was observed with additional particle laden macrophages, similar to 
results reported for SWCNT (Lam et al., 2004; Shvedova et al., 2005; Warheit et al., 2004). Porter 
et al., (2010) showed that an aspiration of dispersed MWCNT caused time-and dose-dependent 
responses of granuloma formation and pulmonary fibrosis. Mercer et al. (2011) reported 
penetration of MWCNT through alveolar epithelial cells into the alveolar interstitial space after 
pharyngeal aspiration of dispersed MWCNT in mice. These findings suggested the need to 
evaluate chronic toxicity of MWCNT at sites within the deep lung.  
 Concerns of occupational exposures have arisen due to the understanding that adverse 
effects occur from MWCNT lung deposition which were observed during animal studies in 
previous years (Muller et al., 2005; Simeonova et al., 2009; Mangum et al., 2006; Li et al., 2007; 
Mercer et al., 2008; Porter et al., 2010; Sager et al., 2014).  The results from an inhalation study 
conducted by Ma-Hock showed that inhaled MWCNT produced lesions in the lung and stressed 
the need to compare various MWCNT toxicities. Selection of MWCNT with the lowest risk for 
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applications would reduce the potential risk of inhalation exposure to humans (Ma Hock et al., 
2009).  A repeated 13-week inhalation study with male and female rats exposed to MWCNT 
showed particle laden alveolar macrophages, increased inflammatory cells and interstitial fibrosis 
(Pauluhn et al., 2010). Both of these exposure studies were essential for the development of a 
recommended exposure limit (REL) in order to protect and prevent lung injury to workers handling 
these types of MWCNT (Pauluhn et al., 2010; Ma-Hock et al., 2009; NIOSH CIB 65).  
2.5 MWCNT induces cardiovascular and systemic toxicities 
The nanotoxicology community began to recognize that pulmonary exposures to MWCNT 
have a unique impact on systemic toxicity. It has been shown that inhalation exposures to MWCNT 
suppressed immune function in mice. Suppression occurred through the activation of signals, 
beginning at the pulmonary tissue and ending with the activation of signals in the spleen (Mitchell 
et al., 2007, 2009). MWCNT exposures have led to serum increases of pro-inflammatory cytokines 
such as, interleukin-6 (Il-6), and the neutrophil chemoattractant, chemokine (C-X-C) ligand 1 
(Cxcl1). Increased serum inflammatory proteins were a result of pulmonary exposure to MWCNT, 
which suggested a corresponding response by systemic tissue. This was verified by increased gene 
expression of Il-6 in aortic tissue (Erdely et al., 2009). These studies demonstrated a close intersect 
between the pulmonary and systemic circulation following exposures to MWCNT. Oropharyngeal 
aspiration in MWCNT to mice promoted susceptibility of cardiac tissue to ischemia/reperfusion 
injury without a pulmonary inflammatory response, suggesting a risk to the cardiovascular system 
in the presence of MWCNT (Urankar et al., 2012). Another study evaluated arteriolar reactivity in 
response to MWCNT inhalation. Results indicated that MWCNT inhalation leads to impairments 
of endothelium-dependent dilation in coronary microcirculation at 24 h post-exposure (Stapleton 
et al., 2012). 
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 Pulmonary exposures to MWCNT requires complex evaluations of cardiovascular 
toxicity, regardless of rodent model (Erdely et al., 2009; Stapleton et al., 2012). A long term 
assessment of systemic toxicity was conducted in 2009 with Wistar rats. This 90-day inhalation 
toxicity study concluded that inhalation exposure to MWCNT produced no systemic toxicity while 
minimal multifocal granulomas and neutrophilic inflammation was observed in lung tissue (Ma-
Hock et al., 2009). In 2010, a study conducted by Jurgen Pauluhn reported that extrapulmonary 
translocation or systemic toxicity was absent in any biological specimens.   
2.6 Post-processing MWCNT  
As discussed, numerous toxicological studies have demonstrated the potential health 
implications following pulmonary exposures to MWCNT in vivo (Shvedova et al., 2005; Mercer 
et al., 2011;Mercer et al 2013a, 2013b; Erdely et al., 2009, 2013). Continued research has 
discovered that alterations to the physicochemical properties of CNT can lead to dramatically 
different ranges of functional end products (Kong et al., 2004; Vaisman et al., 2006; Sahoo et al., 
2010; Martins et al., 2013). Post-processing MWCNT allows manufacturers to tailor large 
quantities of MWCNT for specific use. Post-manufacturing processes include, and are not limited 
to, acid washing, functionalization or polymer coating (Liu et al., 2005; Xiong et al., 2006; Wang 
et al., 2009). Velasco-Santos (2003) explained that functionalized carbon nanotubes bonded to a 
polymer matrix, exhibited enhanced the mechanical properties of a thermoplastic product. 
Functionalization can include, nitrogen doping, amination and esterification of the carboxylic 
groups bound to the surface of CNT (Li et al., 2013). An inverse relationship exists between 
particle size and surface expressed molecules as a result of functionalization. Importantly, the 
number of atoms or molecules attached to the surface of MWCNT may determine material 
reactivity in biological tissue (Nel et al., 2006; Sager et al., 2014). A study in 2013 assessed 
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covalently functionalized MWCNT to assess the impact of surface charge in a toxicological model 
for pulmonary fibrosis. The results demonstrated that surface charge is an important predictor of 
the pro-fibrotic potential of functionalized MWCNT in the lung, with highly negative MWCNT 
being less toxic  and highly positive MWCNT being more toxic (Nel et al., 2009, 2013). Overall, 
post-processing results in dramatically different sizes, shapes, and chemical compositions of 
MWCNT, many of which, have unknown toxicities when compared to the AP-MW in vivo.  
2.7 Polymer-coated MWCNT 
The abundance of research involving CNT and their impact on pulmonary and systemic 
health effects has focused mainly on AP-MW and is well known (Oberdorster et al., 2016 
Bergamaschi et al., 2006; Borm et al., 2004; Donaldson et al., 2002, 2006). A recent advancement 
in the life cycle of MWCNT manufacturing involves polymer-coating MWCNT (PC-MW) for 
numerous reasons, some of which include increased dispersion into composites, ease in handling 
and reduced dustiness without affecting the properties of the native MWCNT (Liu et al., 2005; 
Xiong et al., 2006;).  What remains unknown is the pulmonary toxicity of PC-MW from U.S. 
manufacturing companies in comparison to their AP-MW. 
The French Institute of Health and Medical Research (INSERM) investigated the toxicity 
of MWCNT coated with a polystyrene polybutadiene polymethylacrylate (PMMA) polymer. 
Coating MWCNT with PMMA did not affect the intrinsic properties of the MWCNT and 
decreased cytotoxicity, inflammation and oxidative stress in vitro and in vivo (Tabet et al., 2011). 
Though this group found that a PMMA polymer-coated MWCNT reduced toxicity, it remains 
unclear if other types of polymer coatings affect toxicity of MWCNT in vivo. To more thoroughly 
understand the impact of polymer coatings on the pulmonary toxicity of MWCNT, the current 
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project utilized two PC-MW which are currently being handled in the U.S., and assessed the 
toxicity of these materials compared to their associated AP-MW counterpart. 
 2.8 CNT and potential human health implications 
The U.S. National Science Foundation predicted that a large increase in workers would be 
needed to support the growing field of nanotechnology. They urged the importance of 
toxicological evaluation of nanoparticles before any adverse health consequences could arise as a 
result of handling these materials. Despite the toxicity findings to date regarding CNT, even the 
most modest predictions show continued growth of the industry through 2025 (Future Markets 
Inc., January 2016).  
NIOSH issued a current intelligence bulletin (CIBs) that summarized toxicity research to 
date regarding occupational hazards of CNT. In this document, NIOSH reviewed short-term and 
sub-chronic animal studies involving CNT exposures, which resulted in early stage fibrotic and 
inflammatory lung responses. This compilation of studies was used to establish a recommended 
exposure limit (REL) for individuals handling these materials. NIOSH proposed a recommended 
exposure limit (REL) of 1 µg/m3 of elemental carbon as a respirable mass, based on an 8-hour 
time-weighted average (TWA) concentration. The proposed REL is a recommendation used to 
minimize the risk for pulmonary inflammation and fibrosis to workers handling CNT over a life 
time of exposure, or 45 working years (NIOSH CIB 65). Researchers at NIOSH used this 
recommendation when extrapolating the data from workplace exposures for the design of an in 
vivo inhalation study (Erdely et al., 2013). This inhalation study exposed mice to similar levels of 
MWCNT, based on extrapolations from exposure assessments of U.S-based CNT facilities. Their 
findings showed limited pulmonary inflammatory potential of MWCNT at exposures reported in 
US worksites evaluated by NIOSH, and their estimates suggested a considerable amount of 
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working years (about 76) would be needed to induce significant pathology (Erdely et al., 2013). 
Since the proposed REL was established, an industrywide exposure assessment study was 
conducted to assess occupational exposures to CNT. Of the fourteen total sites visited within the 
study, epidemiologists concluded that all worker exposure samples, based on personal breathing 
zone measurements, were below the NIOSH REL for the respirable fraction (Dahm et al., 2015). 
It is important to understand the interactions of CNT and their impact on pulmonary 
toxicity in rodents in order to generate data that can be used for risk assessment (Oberdorster et 
al., 2015). Our understanding of the toxicological impact can be used to develop predictive 
screening standards at loccupational levels. To achieve this goal, toxicologists must utilize 
exposure assessment studies in order to design in vivo protocols where results accurately reflect 
current worker exposures within the U.S. (Xia et al., 2009; Liou et al., 2015). 
3.0 Study AIM 
The overall objective of the current study was to evaluate and describe the toxicological 
impact of two different AP-MW and their PC-MW counterparts in vivo. Based on previous animal 
studies, it is critical to understand how these materials impact occupational health. To date, little 
is known about the toxicities associated with PC-MW, most of which make their way into 
composite manufacturing for consumer products. Furthermore, research regarding the toxicities of 
these nanoenabled composites is sparse. Ongoing exposure assessment studies from U.S. CNT 
manufacturing facilities were vital to this research as a way to bridge the gap between occupational 
exposure assessments and in vivo animal studies. The research presented here, utilizes the same 
AP-MW and PC-MW currently handled in U.S. facilities which have participated in NIOSH field 
assessments. 
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This study focused on the combination of AP-MW and PC-MW from two separate 
companies (Figure 2). Each company had separate intentions for utilizing polymer coatings. 
Company 1, synthesizes their own branched AP-MW and uses an off the shelf polyurethane 
coating. This company wanted to reduce dustiness of the AP-MW in order for ease of handling 
and involuntary product loss downstream, as this material aerosolizes easily. Additionally, they 
use polyurethane to increase dispersion of MWCNT in liquid medium to improve thermoplastic 
manufacture. Conversely, Company 2 purchases a bulk supply of AP-MW, and coats this material 
with a proprietary poly(arylene ethynylene) (PAE) polymer (Figure 2). Company 2 utilizes this 
polymer to increase dispersion and adhesion to an epoxy matrix which will be used in the 
manufacture of composites.  
 
 
 
 
Figure 2: AP-MW and PC-MW material overview. Each U.S. based company adopts 
different methods for polymer coating. This study focused on the pulmonary toxicity 
following the addition of an off the shelf polyurethane or proprietary polymer to AP-MW 
in vivo.  
Company 1
AP-MW: In house 
synthesis
PC-MW: Polyurethane
Company 2
AP-MW: Bulk purchase
PC-MW: Proprietary 
PAE
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4.0 Methods 
The general experimental approach to assess pulmonary toxicity in vivo, to both AP-MW 
and PC-MW is shown in Figure 3. The hypothesis was that PC-MW would alter toxicity in 
comparison to AP-MW in vivo. Time-and dose-dependent responses were assessed along with 
potential pathological outcomes following exposures. Each chapter herein describes the molecular 
and pathological effects of these pairs of AP-MW and PC-MW following oropharyngeal aspiration 
in a mouse model.  
 
 
 
 
Post-Exposure 
harvest: 4 hr, 1, 7, 
28, 84 d
Bronchoalveolar 
lavage (BAL)
CytotoxicityLactate 
dehydrogenase 
(LDH)
Inflammatory 
proteins and cells
Histopathology Particle distribution 
Pulmonary tissue 
collection
Relative mRNA 
expression
Figure 3: Endpoint analyses following exposure to either AP-MW or PC-MW. Analyses include: 
analysis of BAL for cytotoxicity as measured by LDH, pulmonary inflammatory cell influx and 
protein abundance, and quantitative measurement of relative mRNA expression of pulmonary 
tissue. 
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4.1 Exposure Assessment  
Ongoing research has suggested that occupational exposure to CNT could result in a variety 
of adverse health effects. To address this concern, Dahm et al. (2015) conducted an industry wide 
exposure assessment study of CNT primary and secondary manufacturers. To assess worker 
exposure, this group utilized personal breathing zone (PBZ) samples. Briefly, PBZ samplers are 
attached to the collar of a worker, throughout normal working hours.  Following each shift, PBZ 
samples were collected for analysis of elemental carbon at inhalable and respirable sized fractions 
by transmission electron microscopy. These fractions are assessed to understand the percentage of 
particles that can be inhaled, as well as the fraction that has the potential to reach deep within the 
lungs (respirable). Until more information is available about the effects of CNT on occupational 
health, PBZ elemental carbon (EC) samples are a way to limit potential health risk and to assess 
worker exposure at both the inhalable and respirable sized fractions (Dahm et al., 2015). Fractions 
of material that have the potential to reach larger airways and persist are known as inhalable, while 
respirable sized fractions have the potential to travel deeper within the lung. The representative 
electron microscopy images of PBZ samples collected from both workplaces that handle the 
materials tested for this study were evaluated (Figure 5 and 19). The PBZ TEM images for this 
study were used in order to determine proper dosing methodology for adaptation in a rodent model.  
4.2 Characterization 
Scanning transmission electron microscopy (STEM) images were obtained for all materials 
from Company 1 and 2 using an S-5500 ultrahigh resolution SEM with STEM capabilities (RJ Lee 
Group, Inc., United States). Length and diameter for each material was calculated based on an 
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average of n=200 nanotubes. All measurements for zeta potential, an indicator of surface charge 
in the dosing medium, were performed using a Nano ZS90 instrument (Malvern Instruments, UK). 
Viscosity of control medium was previously determined at room temperature using a VS-10 
viscometer (Malvern Instruments) and used as the value for calculation of zeta potential. The 
agglomeration state of MWCNT can be different for each material depending on the structural 
arrangement of carbon atoms and their interaction with surrounding ions, in solution. Riddick 
(1968) used zeta potential to develop categories that describe the stability of these dispersions in 
liquid media. Essentially, a weak electrical force (-12mV) will allow the material to agglomerate, 
because the particles do not have enough surface charge to repel each other. Normally, a dispersion 
with a large electrical force (-61 to -80 mV) allows particles to remain suspended in liquid, or have 
high stability. X-ray photoelectron spectroscopy (XPS) was utilized to measure the elemental 
surface chemistry of each sample. In addition, hydrodynamic diameter was measured by dynamic 
light scattering (DLS). DLS characterizes nanoparticles by measuring the fluctuations in the 
scattering intensity of a solution over time (Ansell et al., 2011). The measured hydrodynamic 
diameter is a value to explain how a particle diffuses within a fluid, in this case, the physiologic 
medium for in vivo exposures. The hydrodynamic diameter represents the particle size of spherical 
structures once in the physiologic medium. Although this method is not optimal for fibrous 
structures, it can be used to qualitatively infer the degree of agglomeration of CNT. The endotoxin 
contamination was measured using the Limulus Amebocyte Lysate test. Metal content was 
measured by inductively coupled plasma atomic emission spectroscopy (ICP-AES).   
4.3 Study design and particle aspiration  
Male C57BL/6J pathogen-free mice weighing 20-25g were obtained from Jackson 
Laboratories, Bar Harbor, ME. All mice were housed in the assessment and accreditation of 
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laboratory animal care (AAALAC)-accredited NIOSH Animal Facility and afforded food and tap 
water ad libitum in ventilated cages, on autoclaved hardwood chip bedding in laminar flow cages 
and an environment of controlled humidity and temperature. This environment was equipped with 
12 hours of light/dark cycles per day. Animals were allowed to acclimate for at least seven days 
prior to use in any experiments. Animal care and use procedures were conducted in accordance 
with the “PHS Policy on Humane Care and Use of Laboratory Animals” and the “Guide for the 
Care and Use of Laboratory Animals” (NIH publication 86-23, 1996). The procedures utilized in 
this study were approved by the National Institute for Occupational Safety and Health Institutional 
Animal Care and Use Committee.   
Male C57LB/6J mice, eight to ten weeks of age, were exposed by oropharyngeal aspiration 
to either vehicle control or selected MWCNT at two different concentrations, 4 or 40 µg per mouse 
dependent on study design (Figure 4). Physiologic medium, the vehicle, was prepared fresh each 
morning and contained mouse serum albumin (0.6 mg/ml) and pulmonary surfactant (10 µg/ml; 1, 
2-Dipalmitoyl-sn-glycero-3-phosphocholine, DPPC; Sigma Life Science) prepared in United 
States pharmacopeia (USP) grade-phosphate buffered saline (PBS) without calcium and 
magnesium. Low (4 µg) and high (40 µg) dose concentrations were chosen from previous studies 
in order to mimic workplace exposures. The lowest dose was chosen to accurately reflect relevant 
human exposure levels as reported by Erdely et al. (2013).  The low dose is equivalent to 7.6 
working years, a time point representative of the years in operation of these studied facilities within 
the U.S., while the highest dose (40 µg) will elicit pathology within a short time frame (84 d) 
(Erdely et al., 2013). According to the manufacturers, the polymer coatings are 7 and 15% of the 
total weight from Company 1 and Company 2, respectively. Extrapolations were made in order to 
account for the weight of the coating, which was then dispersed in the liquid medium for control 
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dosing purposes. Each dry AP-MW and PC-MW was weighed equally by mass. Each AP-MW 
had a final concentration of 1.6 mg/mL in physiologic dosing medium while the PC-MW samples 
were suspended in 850 or 930 µl of physiologic dosing medium (Company 1 and Company 2 
respectively). Thus, the mass of MWCNT in each sample, regardless of coating, remained similar. 
 
 
 
Each mouse was anesthetized in a bell jar containing a tissue-tek mega-cassette (Sakura) 
packed with gauze, which was moistened with USP grade isoflurane (0.5 mL) (Piramal Healthcare, 
Andhra Pradesh, India). When fully anesthetized, as noted with unsteady gate, decreased mobility 
and tail drop, the mouse was taken out of the bell jar and placed on a slant board (Saffiotti et al., 
1968; Rao et al., 2011). The animal was positioned in such a way that its back, neck and cranium 
rests on the board.  The mouth was gently opened to suspend the mouse by its incisor teeth along 
a thin braided cord. The tongue was pulled aside and extended away from the oral cavity by small 
forceps. A fifty microliter suspension of dosing medium was pipetted at the base of the tongue, 
while tongue restraint continued for five normal breaths to inhale the droplet. Once all the exposure 
C57BL/6J
(8 - 10 
weeks)
Vehicle
Physiologic 
dosing 
medium
AP- MW
4 µg
40 µg
PC-MW
4 µg
40 µg
Figure 4: Experimental Design. Two sets of mice were used for each company, one for 
histopathology as well as pulmonary and systemic tissue gene expression and a second set 
for analyses of BAL samples to determine inflammatory cell influx and cytotoxicity. 
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solution was aspirated by normal respiration, the tongue was released and the mouse was lifted 
from the board, and placed back into the housing unit. Each mouse was observed for a short time 
following this procedure to ensure full recovery from anesthesia. At 0 (4 hours), 1, 7, 28 and 84 d 
post-exposure, mice were euthanized for evaluations of pulmonary responses using two sets of 
mice for each company. The first set of mice was used to determine molecular parameters, 
pulmonary inflammatory cell influx and cytotoxicity using bronchoalveolar lavage fluid (BALF). 
In the second set of mice, right lung lobes were fixed and embedded in paraffin wax, and sectioned 
for determination of lung burden of MWCNT and histopathology. The left lung lobe was ligated 
and frozen in liquid nitrogen for relative mRNA expression.  
4.4 Bronchoalveolar lavage (BAL): 
Mice were anesthetized with an i.p. injection of sodium pentobarbital (100mg/kg body 
weight) at 4 hr, 1, 7, 28 and 84 d post-exposure. Whole blood was collected from the inferior vena 
cava and saved for later analysis. Following euthanization by exsanguination, BAL was performed 
by cannulating the trachea and lavaging the lungs with physiological saline, first at 0.6 mL and 
two subsequent lavages at 1.0 mL for a total of 2.6 mL of BAL fluid (BALF). Lavage collections 
were centrifuged for acellular and cellular fractions. The acellular fraction (< 0.6 ml) of the first 
lavage was kept separate for BALF inflammatory protein analysis (Myriad/ RBM; Austin, TX) by 
multiplex immunoassay RodentMAP v3.1. The acellular BALF fraction was also used to 
determine the cytotoxicity of MWCNT as measured by lactate dehydrogenase activity (LDH). 
Lactate dehydrogenase is a cytoplasmic enzyme present in most cells. A rupture of the cell 
membrane can cause cellular contents, including LDH, to be released to the surrounding fluid. 
Therefore, measuring LDH activity is an indicator of cell damage following MWCNT exposure in 
vivo. The Cobus 400 analyzer series (Roche Diagnostics, North America) quantitatively 
19 
 
determines the catalytic activity of LDH in non-frozen samples by measuring the reduction of 
pyruvate to form L-lactate in the presence of NADH.  
The cellular BALF fractions from both the first and second lavage were combined in a total 
of 800 µL of USP grade PBS. Total cell number was measured using a hemocytometer. A 
hemocytometer is a chamber, that when loaded, allows an individual to tally the number of cells 
in a precise volume of fluid. Using this method, the concentration of cells in the total fluid was 
calculated to determine the total number of cells harvested by BAL. The reconstituted cellular 
fraction of the BALF was loaded into funnels for the Thermoscientific Cytospin 4 (Fisherbrand-
Colorfrost Plus Microscope Slides-Precleaned) and spun (800 g for 5 min) onto slides. 
Differentials from the cellular fraction were made from counts of 300 cells per slide following 
staining by a modified Wright-Giemsa stain. Cells were identified as neutrophils, eosinophils, 
lymphocytes and macrophages. The number of each tell type was determined as the percent cell 
type multiplied by the total number of cells. Pulmonary inflammation is indicated by an elevation 
in neutrophils harvested by BAL.  
4.5 Pulmonary gene expression 
Lung tissues were dissected and immediately frozen in liquid nitrogen. All samples were 
stored at -80° C prior to analysis. RNA was isolated from pulmonary tissue using the RNeasy Mini 
Kit (Qiagen, Valencia, CA, USA). Pulmonary gene expression was determined by standard 96-
well technology using the StepOne Plus (Applied Biosystems, Carlsbad, CA, USA) with pre-
designed Assays-on-Demand TaqMan probes and primers including Il-6 (Mm00446190_m1), 
Ccl22 (Mm00436439_m1), Cxcl2 (Mm00436450_m1), Ccl2 (Mm00441242_m1), and Spp1 
(Mm00436767_m1) (Applied Biosystems). Using 96 well plates,  RNA (1 µg) was reverse 
transcribed using random hexamers (Applied Biosystems) and Superscript III (Invitrogen, 
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Carlsbad, CA, USA). Dilute cDNA (1/10) was used for gene expression determination. 
Hypoxanthine-guanine phosphoribosyltranferase (HPRT) was used as the endogenous reference. 
Relative gene expression was calculated using the comparative threshold method (2-ΔΔCt) with 
vehicle-treated mice serving as the reference group (Schmittgen et al., 2008).  
4.6 Particle distribution  
To understand particle deposition following exposure, one hematoxylin and eosin (H&E) 
stained section of lung was examined at 10X magnification. Based on the relative amount of 
particle/size of the deposit (small, medium, large and extra-large) each focused deposition was 
scored individually from 1-4. Minimal depositions or small deposits were scored with a one. This 
included small clusters of particle-laden macrophages, or particularly small extracellular deposits 
of particles. Individual alveolar macrophages containing particles were difficult to view at low 
magnification. Scores incrementally increased with increasing deposition; a score of four included 
extensive deposition or extremely large deposits. This score included airways with entangled 
particles or extracellular aggregates. This score does not account for plugged airways in each 
sample. To normalize the data and compensate for different amounts of aspired particles, burden 
in each lung region was expressed as a percent of the total lung burden. Percent of particle burden 
was tabulated for bronchioles, terminal bronchioles, alveolar ducts and alveolus. By choosing to 
represent particle burden as a percent of the total lung burden, it is easy to make comparisons 
between lung regions and understand location of particle distribution following exposure. 
4.7 Histopathology  
Mice were euthanized and the left lung lobe was excised and frozen, while the remaining 
right lung lobes were inflated with 10% buffered formalin. Following fixation, right lung sections 
were cut, stained with H&E and interpreted by a board certified veterinary pathologist, who was 
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blinded with respect to treatment group. Presented in this thesis are initial qualitative observations 
of histopathology with respect to AP-MW vs PC-MW. The pulmonary pathology that MWCNT 
can induce in vivo is well-established, the particular goal was to report any unique observations of 
effect due to polymer coatings. Quantitative measures of inflammation, granuloma formation, and 
fibrosis are in process. 
4.8 CytoViva hyperspectral imaging 
CytoViva technology integrates enhanced darkfield-based microscopy with high resolution 
hyperspectral imaging. Sirius Red staining consists of immersing slides in 0.1% picosirius 
solution, the left lung tissue stained with Sirius Red were mounted and cover slipped for use in the 
dark field imaging. This unique preparation helps distinguish MWCNT from normal tissue. 
Nanoparticles within the lung sections were imaged using a darkfield-based illumination on an 
Olympus BX-41 microscope (CytoViva, Auburn, AL) at 100X oil immersion. The combination of 
the CytoViva hyperspectral imaging and CytoViva microscope system has been used previously 
to quantify the presence of MWCNT in tissues (Mercer et al., 2013). Staining of extracellular 
matrix components helps to understand tissue remodeling and connective tissue pathologies 
(Mercer et al. 2011, Lattouf et al., 2014). This technique enhances the contrast between biological 
tissue and MWCNT (Mercer et al., 2011). Carbon nanotubes have properties that allow them to 
scatter light very differently than biologic tissues or mounting medium. These materials scatter 
light to a greater extent than surrounding tissue, thus nanomaterials in a given section stand out as 
bright white structures. Using this method, lung sections can be assessed through low 
magnification to identify areas of CNT in tissue that would not normally be detected by other 
traditional light microscopy techniques (Mercer et al., 2011).  
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5.0 Statistics 
Data from rodent studies were log transformed prior to analysis to meet the assumptions 
of the statistical tests. Analysis of Variance (ANOVA) was done using JMP 11 with a Least 
Squares Means table by Student’s t-test as a post-hoc test. Pairwise comparisons were performed 
using Student’s t-test. Differences between experimental groups were considered significant with 
p-values less than 0.05. 
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6.0 Chapter 1: Company 1 
6.1 Introduction 
Manufactured MWCNT have the attention of physical chemists and scientists because of 
their vast potential for industrial application. However, the occupational information regarding the 
health impacts from handling these materials along their life cycle, is lacking. The first aim of this 
project involved characterizing, preparing and exposing mice to an as-produced, branched 
MWCNT (AP-MW) or the post-processed version, a polyurethane coated AP-MW (PC-MW). 
Company 1 utilizes a unique proprietary process to create the branched MWCNT, which are then 
coated with polyurethane in order to ease handling and aide in composite manufacturing. The 
pulmonary toxicities of these materials remain unknown. When PC-MW are added to polymer 
matrices (e.g. thermoplastics), the end result is a product with enhanced properties such as 
increased strength and conductivity. This company offers a MWCNT-infused product that is 
highly sought out by automotive, aviation, and construction industries.  
The branched AP-MW is produced, utilized, and handled on a daily basis by facility 
workers. Figure 5 shows the type of material these workers have been exposed to during normal 
working hours. The material from Company 1 exists in a tangled web-like form, comprised of 
several hundred entangled MWCNT as seen in personal breathing zone (PBZ) collections. A goal 
of this study was to prepare the materials for animal studies that closely mimicked the PBZ samples 
(Figure 5).  With that in mind, toxicological responses following in vivo exposures, can be directly 
correlated to human health exposures.   
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Following bulk synthesis, the branched AP-MW are packaged by facility workers and 
transported to an offsite facility for post-production modifications. Company 1 selected to coat 
their base material, the branched AP-MW, with a thin layer of polyurethane. This company chose 
to utilize a polyurethane coating in order to reduce the dustiness associated with dry powder 
handling. Polyurethane makes up 7% of the total weight of bulk material (AP-MW plus polymer) 
and was accounted for so that the mass of MWCNT in each AP-MW and PC-MW sample remained 
similar. Continuing along the occupational life cycle for MWCNT, the PC-MW are incorporated 
into composites. These composites are manipulated by facility workers (sanding or grinding) to 
generate the final product. In vivo exposures are ongoing to determine the toxicological impact of 
particles generated from sanding composites containing PC-MW. 
 
          
     Personal Breathing Zone                      AP-MW in liquid medium 
          
Figure 5: Representative TEM images of MWCNT. Images obtained from personal breathing zone 
sampling from facilities (left panels) mirrored samples prepared in dispersion medium for in vivo 
exposures (right panel). Facility relevant exposures are crucial when extrapolating the effects of 
in vivo studies to human health relevance. 
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6.2 Results 
6.2.1 Characterization 
Prior to in vivo exposures, extensive morphological characterization of AP-MW and PC-
MW was evaluated. Images obtained from PBZ were utilized to compare in vivo material 
preparations (Figure 5). Material was dispersed in organic solvent and visualized with a scanning 
transmission electron microscope (STEM), to verify their width distribution (Figure 6).  Since the 
polymer coating makes up 7 % of the weight AP-MW and PC-MW were weighed by mass and 
dispersed in physiologic dosing medium, at either 1.6 mg/mL for AP-MW or 1.6 mg/930µl for 
PC-MW. Each dimension was calculated through an average of n=200 nanotubes. Mean widths of 
both materials were similar, approximately 16 nanometers in diameter, regardless of coating. In 
               
 
Figure 6: The diameter distribution of both particles is shown (left). STEM images confirm that the 
widths of both types of particles, regardless of coating, are similar. 
PC-MW
AP-MW
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addition to STEM images, Table 1 shows the characterization data for each material obtained for 
Company 1. 
 
 
Material 
Mean 
Length 
(µm) (SD) 
Length 
Range 
(µm) (SD) 
Mean 
Width 
nm (SD) 
Width 
Range 
(nm) 
Zeta 
Potential 
(mV) 
Hydrodynamic 
Diameter 
(nm) 
Company 1 
AP-MW 2.08 (3.8) 0.22-50.9 16.5 (18.1) 6.3-216 -12.1±0.6 771±33 
Company 1 
PC-MW 1.71 (1.6) 0.01-8.5 16.2 (22.0) 6.3-283 -11.9±0.5 676±8 
 
The branched AP-MW from Company 1 is slightly longer with relatively the same mean 
width as the PC-MW. Both materials obtained from Company 1 agglomerated easily in solution (-
11 to -12 mV). XPS also confirmed that a high degree of oxygen molecules were bound to PC-
MW in comparison to AP-MW (Figure 7) indicating the polyurethane coating. Endotoxin levels  
 
were below the level of detection (data not shown) and the percent weight of metal catalyst (1.7% 
iron) was similar between the AP-MW and PC-MW. Following characterization, animals were 
exposed to either: physiologic dosing medium (control), 4µg, or 40 µg of AP-MW or PC-MW 
Table 1: Material characterization. Regardless of coating, mean widths were around 16.0 nm. 
However, lengths between the two materials ranged from 0.22-50.9 µm. 
 
 
Figure 7: PC-MW contains more oxygen than AP-MW in survey scans confirming presence 
of polymer coating as indicated by the O1s peak (right). Often, polymer coatings are confirmed 
by a higher oxygen content on samples of MWCNT.   
 
AP-MW PC-MW
O KLL O1s
C1sC1s
O1sO KLL
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(Figure 4). The lowest dose (4µg) equates to a cumulative deposited dose of exposures seen in 
evaluated workplaces to date (about seven years) (Erdely et al., 2013). In fact, this dose was 
calculated based on information gained from an exposure assessment study of workers exposed to 
elemental carbon at 10.6 µg/m3 over an 8 hour day. The high dose (40 µg) was chosen to 
understand pathological outcomes.  
6.2.2 Company 1: Pulmonary cytotoxicity, inflammatory cell influx and protein expression  
Following exposure, both AP-MW and PC-MW elicited pulmonary cytotoxicity, 
inflammatory cell influx and increases in mRNA expression of proinflammatory cytokines, which 
was time-and dose-dependent (Figure 8-10).   
      
Figure 8: Cytotoxicity of AP-MW and PC-MW as measured by lactate dehydrogenase activity over 
4 hr, 1, 7, 28, and 84 d post-exposure. All materials were cytotoxic however, no difference was seen 
between AP-MW and PC-MW exposed groups. N=6 per group.*p < 0.05 vs DM. 
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Company 1 elicited cytotoxicity, measured by lactate dehydrogenase activity, which was 
significantly different from control and resolved with time. The high dose of PC-MW was not 
significantly different from AP-MW (Figure 8). An increase in total cells, polymorphonuclear 
leukocytes (PMN) (neutrophils and eosinophils), and alveolar macrophages (AM) was observed 
in high dose exposures but no difference was observed as a result of coating over time (Figure 9, 
10, 11). The influx of PMN was highest at 4 hr post-exposure and resolved by 84 d. Total cells, a 
result of increased macrophages, peaked at 7 d post-exposure.  The lowest dose (4 µg), regardless 
of coating, did not result in any significant PMN cell influx. 
 
                        
Figure 10: Bronchoalveolar lavage protein profiling (multiplex immunoassay RodentMAP 
v3.1, Myriad, RBM). Inflammatory cytokines were elevated at 1d post-exposure but resolved 
by 28d. No significant difference seen between AP-MW and PC-MW exposed groups.  
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Figure 9: Polymorphonuclear leukocyte (PMN) inflammatory cell influx following exposure to AP-
MW or PC-MW. Inflammatory cells peaked at 7d post-exposure but return to baseline by 84d. No 
significant difference was seen between AP-MW and PC-MW exposure groups. PC-MW did not 
increase inflammatory cell influx compared to AP-MW. N=6 per group.*p < 0.05 vs DM. 
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Figure 11: Total Cells following exposures to AP-MW or PC-MW. Increased total cell influx was 
noticeable in the high dose exposure groups compared to sham and peaked at 7 d post-exposure. PC-
MW exposed groups were not significant from AP-MW at a similar dose, except at 4 hr post-exposure. 
N=6 per group. *p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose. 
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Figure 10: Total alveolar macrophages (AM) following exposure to AP-MW or PC-MW. AM from 
high dose exposures peaked at 7 d and resolved over time.  At 4 hr, PC-MW was significantly different 
from AP-MW at similar dose. N=6 per group.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose. 
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Figure 12 shows isolated alveolar macrophages (AM) in direct contact with both AP-MW and PC-
MW at 1 d post-exposure. Large entanglements of AP-MW and PC-MW made it difficult for AM 
engulfment. AP-MW and PC-MW continued to exist as tangled clusters following exposures 
(Figure 12). It is possible that the AM interact with AP-MW and PC-MW and were unable to 
separate these large bundles. Evidence of large bundles in contact with AM confirmed that these 
materials remained agglomerated in vivo, which directly correlated with how these materials exist 
in the workplace (Figure 5). 
                                         
Figure 12: Attempted engulfment of material by alveolar macrophages (AM) at 1 d is shown (AP-
MW- left; PC-MW – middle and right). All particles remained as web-like aggregates in vivo.  
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 These materials adversely affected inflammatory BAL proteins and gene expression in 
pulmonary tissue (Figure 13 and 14). Pulmonary gene expression for inflammatory mediators, 
including interleukin-6 (Il-6), were significantly different from control at 4 hr, 1 and 7 d post-
exposure in low and high dose AP-MW and PC-MW exposed groups (Figure 13). Relative mRNA 
expression of chemokine (C-C motif) ligand 22 (Ccl22; also referred to as macrophage derived 
chemokine) was significantly different in the high dose groups at 7 d post-exposure, regardless of 
dose. Additionally, mRNA expression for mediators including, interleukin 1 beta (Il-1b), 
chemokine (C-X-C motif) ligand 2 (Cxcl2), chemokine (C-C motif) (Ccl2), and secreted 
phosphoprotein 1 (Spp1) increased expression and resolved over time (data not shown). Overall, 
the relative mRNA expression of proinflammatory cytokines in PC-MW exposed groups was not 
significantly different from AP-MW.   
A multiplex protein profile was generated to understand the regulation of inflammatory 
proteins from BALF (Figure 14). BAL proteins were analyzed with rodent multi-analytic profile 
(rodent MAP v3.1, Myriad, RBM). 
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Figure 13: Relative mRNA expression of AP-MW and PC-MW isolated from pulmonary tissue at 4 
hr, 1, 7, 28 and 84 d post-exposure. Gene expression of Il-6 (left), and Ccl22 (right) were upregulated 
with peak expression at 7 d post-exposure that returned to baseline by 84 d. N=6 per group. *p < 0.05 
vs DM, #p < 0.05 vs AP-MW of similar dose. 
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Figure 14: Heat map of inflammatory proteins at 1 d and 28 d post-exposure. Significant 
downregulation is represented green, while red is significant of up regulation (Log2 fold 
change). Time-and dose-dependent responses were observed. Additionally, polymer coating 
from Company 1 had no additive effect on BAL inflammatory protein abundance. 
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The rodent MAP analyzed fifty-two proteins within a sample of BALF. A time- and dose-
dependent response of BAL inflammatory proteins was noted. In addition, the abundance of 
proinflammatory cytokines (Il-6 and Ccl22) were upregulated at the high doses of AP-MW and 
PC-MW (Figure 14); these data complemented the increase of relative mRNA expression in 
pulmonary tissue. Areas of red color correlate with an increase in protein abundance (log2 fold 
change) while green was indicative of down regulation, with corresponding gradients in between. 
Based on the heat map, the PC-MW had similar effects on BALF protein levels when compared 
to the AP-MW of Company 1, which resolved by 28 d post-exposure.  
6.2.3 Histopathology observations 
Tissues from mice were harvested at 1 and 84 d post-exposure for pulmonary pathology. 
At 84 d post-exposure, both AP-MW and PC-MW deposited in pulmonary tissue as large 
extracellular aggregates within the airways (Figure 15). In particular, the high dose of AP-MW 
was found primarily within the bronchioles, entwined with resident cells. Mild neutrophilic 
inflammation was seen in the bronchioles of high dose exposure groups.  
 
 
 
                    
Figure 15. Histopathology of lung sections from exposed mice.  For both materials, the majority of 
particles were seen within the lumen of small bronchioles. Qualitative observation confirmed particle 
location within nodular aggregates of inflammatory cells (black arrows). 
 
Bronchiole
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Sirius Red staining confirmed the deposition of AP-MW and PC-MW in bronchioles at 84 
d (Figure 16) and enhanced dark field microscopy validated this finding (Figure 17). The 
deposition of nanotubes was clearly seen in enhanced dark field imaging as the bright white regions 
within the bronchiolar space. Taken together, the images from both Sirius Red staining and 
enhanced dark-field imaging show that there were little signs of a fibrotic response and most 
particles deposited in the bronchioles were cleared by 84 d post-exposure. The effects of PC-MW 
exposure was not significantly different compared to AP-MW exposed groups.  
                             
Figure 16: Representative pulmonary tissue 84d post-exposure (0.1% picosirius red staining; nuclei 
counterstained with hematoxylin and eosin (H&E)). Both AP-MW (left) and PC-MW (right) were 
persistent in pulmonary tissue as clusters (>20 microns) in airways. Minimal to no alveolar fibrosis 
was observed.  
             
Figure 17: Enhanced darkfield imaging of pulmonary tissue 1d post-exposure. Initial distribution of 
particle deposition in the lungs were similar between AP-MW (left) and PC-MW (right). Large dense 
clumps (>20 microns) were concentrated in small airways and alveolar regions proximal to the 
terminal bronchiole. (Oil immersion 100X). 
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For the AP-MW exposed groups, deposited particles were observed occurred primarily in 
the bronchioles and were mostly cleared by 84 d (Figure 18). The fraction of AP-MW and PC-
MW that deposited in alveolar space was persistent, when comparing 1 and 84 d post-exposure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.3 Discussion 
Overall, both the AP-MW and PC-MW from Company 1 induced pulmonary cytotoxicity, 
increased inflammation and induced pathology. The response to these materials elicited a time-
and dose-dependent response of pro-inflammatory cytokines as well as increased inflammatory 
protein abundance in BAL. The PC-MW did not increase the pulmonary toxicity compared to the 
base material. Pulmonary responses between both AP-MW and PC-MW groups were generally 
                
Figure 18: Due to agglomeration, these particles were deposited mostly in the bronchioles. The 
fraction in the bronchioles was cleared by 84 d post-exposure, while the fraction in alveolar regions 
persisted. This graphical representation was used to show general particle distribution, quantitative 
confirmation of deposition is ongoing. 
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similar including altered pathology. The material was comprised of web-like bundles and 
continued to exist in this form following exposure (Figure 5, 12, 15, 16). The results from these 
exposures correlated with previous rodent models in which exposures to MWCNT caused 
pulmonary inflammation, as well as a foreign body response to larger agglomerates (Ma-Hock et 
al., 2009; Pauluhn et al., 2010; Mercer et al., 20113a). Qualitative assessments affirmed primary 
particle deposition within the bronchioles and was mostly cleared by 84 d post-exposure.  
Company 1 chose to coat their branched AP-MW with polyurethane (PC-MW) for various 
reasons. This includes, increased dispersion into composites and thermoplastics as well as 
increased the ease of handling. When incorporated into composites, the PC-MW have a high elastic 
modulus (stiffness) which is advantageous for structural material development. Another reason is 
to alter the density and organize PC-MW into a uniform network. This technique aides 
compounding processes to create multifunctional thermoplastics. Most polyurethanes are 
thermosetting polymers that do not melt when heated (Xiong et al., 2006; Wohlleben et al., 2013). 
As a result of this mixture, the coating exploits the inherit natures of MWCNT to dissipate heat. It 
has been shown that composites with 0.5-1% weight of MWCNT increased thermal conductivity 
by 60% when compared to plastics alone (Zhao et al., 2011). For this reason, 3% PC-MW by 
weight in composites is utilized by this particular company.  More recently, the manufacturing of 
thermoplastics has become extremely efficient. Smaller quantities of PC-MW are needed to 
maintain the same level of thermal enhancement.  
While incorporation of PC-MW has many manufacturing benefits, dry powdered AP-MW 
can present adverse health effects to workers handling this material. Dahm et al. (2011), reported 
that the highest amount of exposures to elemental carbon occurred during tasks of dry powder 
handling at facilities manufacturing CNT. The addition of polyurethane to AP-MW provides 
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additional occupational benefits as the “highly-entangled” PC-MW prevent individual MWCNTs 
from being released thereby reducing the risk to workers. The potential inhalation exposure is 
further diminished when smaller quantities of PC-MW are needed for composite manufacture (e.g. 
thermoplastics), which reduces the amount of dry powder handling done by facility workers. The 
company claims that PC-MW are easier to handle, presumably by the reduced dustiness, and this 
benefits packaging processes. It is clear that PC-MW infused products can provide new 
opportunities in consumer products as well as benefiting workers by reducing the potential for 
occupational exposures (Wohlleben et al., 2013).  
Qualitative evaluations of lung sections from AP-MW and PC-MW exposed groups 
revealed adverse effects within the bronchioles (Figure 15, 16, and 17). These effects were similar 
for AP-MW and PC-MW. Particle deposition was primarily confined to the upper airways. Of the 
particles that were deposited in the bronchioles (AP-MW or PC-MW), most had been cleared from 
pulmonary tissue by 84 d post-exposure (Figure 18). Qualitative observations of alveolar fibrosis 
and collagen formation at 84 d post-exposure were absent likely due to the fact that most of this 
material was deposited in the upper airways and was subsequently cleared (Figure 16 and 17). 
Though the results above were qualitative, similar histopathological studies were described 
previously using another type of MWCNT (Mercer et al. in 2011). Following exposure to 
MWCNT 56 d post-aspiration, a significant interstitial increase of collagen fibers at high doses 
(40-80 µg) was observed. A dose-responsive increase in average thickness of alveolar connective 
tissue at 56 d post was noted. They concluded that a lower accumulation of MWCNT in the 
alveolar interstitium resulted in a lower fibrotic related response. Based on the results from Mercer 
et al. (2011), it is likely that quantitative assessments would reveal an absence of a fibrotic reaction 
at later time points (28 and 84 d) due to lower alveolar deposition (Figure 18). 
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Of the particles that remained in the lung at 84 d post-exposure, several (AP-MW or PC-
MW) particles were contained in nodular agglomerates of inflammatory cells within the lumen of 
small bronchioles (Figure 15- black arrows). No significant differences were observed when 
comparing the AP-MW and PC-MW groups. Since most material was cleared from the upper 
airways, the presence of granuloma formation in alveolar regions was reduced due to low material 
persistence. In 2011, Mercer et al. explained that the occurrence of MWCNT in the airways at 7, 
28 or 56 days post-aspiration was minimal (Mercer et al., 2011). In that same study, granulomatous 
lesions in alveolar airspace accounted for only 20% of the total lung burden. At similar mass doses 
of 40 µg, granulomatous lesions were relatively rare but, when present, were located near alveolar 
regions close to terminal bronchioles. If deposits of MWCNT in airspaces are not effectively 
cleared, a network of highly rich connective tissue can form an outgrowth in order to separate these 
poorly cleared particles. This type of response is observed in lungs where insoluble and/or 
particulate matter is poorly cleared (Mercer et al., 2011). 
A large occupational exposure assessment study conducted in 2015 was able to quantify 
both the inhalable and respirable fractions of EC in a number of facilities producing CNT (Dahm 
et al., 2015). It was determined that the AP-MW from Company 1 has a respirable fraction of 3% 
(Dahm et al., 2015). If the percent deposition in vivo is correlated to occupational health, only a 
small fraction of that 3% would reach the alveolar region. Therefore, if a worker were exposed 
during normal working hours, it is likely that most material would deposit in upper bronchioles, 
with high probability of clearance according to our results. Ongoing assessments must consider 
the impact of both inhalable and respirable sized particles on occupational health.  
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7.0 Chapter 2: Company 2 
7.1 Introduction  
The second company taking part in this study purchases bulk master batches of MWCNT 
from a primary manufacturer. The base material is coated with a proprietary poly(arylene 
ethynylene) (PAE)  polymer (Figure 2). This proprietary coating makes up 15% of the total weight 
after being processed (AP-MW plus proprietary coating). Similar to Company 1, Company 2 has 
introduced innovative materials to customers in aerospace, automotive and sporting equipment 
industries. One of the key reasons they utilize a proprietary polymer coating is to improve the 
interaction between MWCNT and resin systems. Although MWCNT are incredibly strong and 
used in distinct applications, they aren’t easily incorporated into resins because of their inherent 
qualities to agglomerate in solution (Pegel et al., 2008). The unique PAE coating creates a non-
covalent interaction between the MWCNT. Next, the incorporation of this PC-MW into a resin 
makes a stronger, more durable material. Additionally, this method effectively reduces the amount 
of base material needed to reach the same endpoints of strength and durability. While many 
companies use 1-5 % CNT by weight in composites, this company only utilizes 0.15%.   
PBZ images obtained from facilities handling this AP-MW shows MWCNT in tight 
bundles and clusters. Preparations of AP-MW closely mimics workplace exposures (Figure 19). 
Each exposure was identical to the methods carried out for Company 1 (Figure 3 and 4). It was 
hypothesized that PC-MW would alter toxicity compared to AP-MW, in vivo. Following time-and 
dose-dependent exposures, it was verified that exposures to PC-MW does in fact alter pulmonary 
toxicity in comparison to AP-MW in vivo.  
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7.2 Results  
7.2.1 Characterization  
Representative PBZ TEM images of material obtained from Company 2 detail 
characteristics of this material. When in dispersion medium, this material tends to form small 
clusters around 500 nm (Figure 19). In addition, both particles (AP-MW or PC-MW) remain 
similar in their diameter distribution (16 nm) and STEM images confirmed that polymer coating 
does not increase particle diameter (Figure 20). AP-MW are longer in length and higher in 
hydrodynamic diameter compared to PC-MW (Table 2). The surface chemistry of the PC-MW is 
different than AP-MW and analysis by XPS confirms a higher amount of oxygen bound to PC-
MW compared to AP-MW, confirming the polymer coating (Figure 21). The catalytic metals were 
similar (2% aluminum and 1.7% iron) and endotoxin was below the level of detection (data not 
shown).  
 
            Personal Breathing Zone                  AP-MW in liquid medium  
                                
Figure 19: Representative TEM images of MWCNT. Images obtained from personal breathing zone 
sampling from facilities (left panel) mirrored samples prepared in dispersion media for in vivo 
exposures (right panel). Relevant facility exposures are crucial when extrapolating the effects of in 
vivo studies to human health relevance. 
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Figure 20: The diameter distribution of both particles is shown (left). STEM images confirm that both 
types of particles are generally similar (right).   
AP-MW
PC-MW
              
Figure 21: X-ray photoelectron microscopy detailed the surface chemistry of AP-MW and PC-MW. According 
to peaks, PC-MW contained more oxygen than AP-MW in survey scans confirming coating. 
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7.2.2 Cytotoxicity, pulmonary inflammation and protein analysis 
Both materials were cytotoxic and induced an inflammatory cell influx compared to control 
groups (Figure 22-25). Cytotoxicity was attenuated following PC-MW exposure and resolved over 
time (Figure 22). No significant effect was observed for the low dose groups. Total PMN influx 
was increased at 4 hr, and 1 d post-exposure, and both high dose groups were significantly different 
from sham. By day 7, only the AP-MW exposed groups was significant. The high dose AP-MW 
groups at 4 hr post-exposure, was significantly different than the PC-MW at the same dose (Figure 
23). Likewise, total cell and alveolar macrophage influx were attenuated in the high dose PC-MW 
groups at 7 and 84 d post-exposure (Figure 24 and 25). Alveolar macrophages were observed 
engulfing particles of AP-MW and PC-MW (Figure 26). 
 
Material Mean 
Length 
(µm) 
(SD) 
Length 
Range 
(µm) (SD) 
Mean 
Width 
nm (SD) 
Width 
Range 
(nm) 
Zeta 
Potential 
(mV) 
Hydrodynamic Diameter 
(nm) 
Company 2 
AP-MW 
1.28 
(1.1) 0.10-8.51 
25.5 
(34.9) 7.8-275 -11.1±0.6 608±30 
Company 2 
PC-MW 
0.77 
(0.4) 0.15-2.44 
15.2 
(3.50) 8.6-32.0 -10.7±0.4 360±12 
Table 2: Particle characterization for AP-MW and PC-MW. Mean widths of all materials remain 
similar, regardless of polymer coatings while hydrodynamic diameter is altered in PC-MW.  
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Figure 22: Cytotoxicity of AP-MW and PC-MW as measured by lactate dehydrogenase 
activity over 4 hr, 1d, 7d, 28, and 84d post-exposure. All materials were cytotoxic; however, 
differences are seen in PC-MW exposed groups compared to similar dose of AP-MW. N=6 per 
group.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose. 
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Figure 23: Polymorphonuclear leukocyte (PMN) Inflammatory cell influx following exposure 
to AP-MW or PC-MW. Inflammatory cells peaked at 7d post-exposure to PC-MW, but return 
to baseline by 84d. A significant difference was seen between AP-MW and PC-MW exposure 
groups at 4 hr post-exposure. PC-MW did not increase inflammatory cell influx compared to 
AP-MW. N=6 per group.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose. 
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Figure 24: Total alveolar macrophages following exposure to AP-MW and PC-MW. High 
dose exposures caused the greatest increase in alveolar macrophages at 7 d with significance 
in AP-MW exposed groups. N=6 per group.*p < 0.05 vs DM. 
 
4 hr 1d 7d 28d 84d
To
ta
l A
lv
eo
la
r M
ac
ro
ph
ag
es
0.0
5.0e+5
1.0e+6
1.5e+6
2.0e+6
2.5e+6 DM 
As Produced - 4 ug
As Produced - 40 ug
Post-Coated - 4 ug
Post-Coated - 40 ug
*
                    
Figure 25: Total pulmonary cell influx following exposures to AP-MW and PC-MW over 
time. As expected, high dose exposure groups elicited the greatest responses at 7 d post-
exposure and PC-MW was significantly different than AP-MW at similar dose at this time 
point.*p < 0.05 vs DM, #p < 0.05 vs AP-MW of similar dose. 
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MRNA for inflammatory cytokines (Il-6 and Ccl22) were significantly increased from 
control in the high dose AP-MW and PC-MW exposed groups (Figure 27). Similar results were 
found for relative mRNA expression of Il-1b, Cxcl2, Ccl2 and Spp1 (data not shown). At 1 and 7 
d post-exposure, relative mRNA expression for these cytokines were attenuated in the high dose 
PC-MW groups compared to AP-MW (Figure 27). In addition to relative mRNA expression, BAL 
inflammatory protein levels were elevated at 1 d post-exposure with attenuation by 28 d post-
exposure. At 1 d post-exposure, pro-inflammatory proteins, in general, associated with PC-MW 
exposure were lower compared to the AP-MW, at the same dose (Figure 28). Together, relative 
mRNA expression was time-and dose-dependent and complementary to BAL protein regulation 
(Figure 27 and 28).  
 
 
                           
Figure 26: Alveolar macropages (AM) successfully engulfing AP-MW and PC-MW. Often 
particles were seen as dense clumps within AM (AP-MW-left and middle; PC-MW- right).  
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      Il-6         Ccl22 
      
Figure 27: Pulmonary inflammatory mRNA expression of interleukin-6 (Il-6) and chemokine (C-C 
motif) ligand 22 (Ccl22). Generally, Il-6 was increased relative to sham and resolved over time. 
Significant attenuation of Il-6 was observed in PC-MW exposed groups compared to similar dose of 
AP-MW (left). Relative expression of Ccl22 was greatest in high dose exposures, while PC-MW 
exposed groups were significantly different at 1 and 7 d post-exposure (right). N=6 per group. *p < 
0.05 vs DM, #p < 0.05 vs AP-MW of similar dose. 
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Figure 28: BAL inflammatory protein regulation at 1 and 28 d post-exposure to AP-MW and 
PC-MW. Time-and dose-dependent responses were observed for all materials. Overall, BAL 
inflammatory proteins were altered in PC-MW groups.  
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Following exposure, inflammation, granuloma formation and particle distribution were 
evaluated in pulmonary tissue samples. Clusters of AP-MW and PC-MW were located around 
terminal bronchioles (Figure 29). Alveolar fibrosis was qualitatively analyzed and no pronounced 
increase was observed (Figure 30). At 84 d post-exposure, small clumps of AP-MW were found 
in macrophages in regions of alveolar airspace.  
 
Figure 30: Representative pulmonary tissue 84d post-exposure (0.1% picosirius red staining; 
nuclei counterstained with hematoxylin and eosin (H&E)). Images of collagen fibers in AP-
MW (left) and PC-MW (right) exposed lungs at 84 d post-exposure. Sections of alveolar 
regions laden with AP-MW (left) and minimal collagen fiber formation.  
         
 
Figure 29: Qualitative pathological evaluation showed majority of AP-MW (left) near terminal 
bronchioles. In contrast, PC-MW (right) were seen as large aggregates and do not elicit the 
same pathological consequences consistent with AP-MW exposed lungs. 
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Figure 31: Enhanced darkfield microscopy of AP-MW at 24 hr (left) and 84 d (right) post-
exposure. Large particles were seen deposited at bronchiole to alveolar duct junctions (left) 
while 84 d post-exposure particles were viewed inside alveolar macrophages (right) (oil 
immersion 100X). 
                    
Figure 32: Particles mostly deposited both the bronchiole and alveolar regions. Particles that 
remained at 84 d exhibited persistence in alveolar regions. The fraction deposited in the 
bronchiolar regions were effectively cleared. 
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Mild inflammation of neutrophils was associated around particle deposits. In contrast to AP-MW, 
fewer particles of PC-MW were present within alveolar macrophages. Some of the material existed 
as extracellular aggregates and lacked associated inflammatory cells (Figure 29). Granuloma 
formation was apparent in AP-MW groups at 84 d (Figure 29 - left) but absent in PC-MW groups 
(Figure 29 – right). High dose exposures were associated with particle deposition around terminal 
bronchioles and alveolar ducts as seen in EDM (Figure 31). Minimal to no inflammation was noted 
and particle abundance of PC-MW was significantly less than the AP-MW.  
Biodistribution of particles was assessed to understand deposition in the bronchiole and 
alveolar regions. Depositions of both particles were observed in the bronchiole and alveolar space. 
Of the total percent deposited at 1 d post-exposure, the high dose of AP-MW and PC-MW mainly 
deposited in alveolar regions (both 75%). At 84 d post-exposure, the largest fraction of the total 
deposition remained in the alveolar space for both AP-MW and PC-MW. Particle clearance 
occurred in the bronchioles while the remaining percent deposition in alveolar regions persisted 
over time (Figure 32).  
7.3 Discussion 
A purchased bulk supply of MWCNT was coated with a proprietary PAE polymer in order 
to enhance dispersion for composite material application. Overall, exposures to AP-MW and PC-
MW induced time- and dose-dependent responses of pulmonary cytotoxicity, inflammation, and 
increased inflammatory protein abundance in BAL compared to sham treated mice. Based on 
results, the pulmonary toxicity of PC-MW exposed groups was attenuated in comparison to AP-
MW treated groups. Primary particle deposition occurred within the alveolar regions which 
persisted at 84 d post-exposure. Qualitative observations of pathology indicated AP-MW exposed 
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groups exhibit signs of granuloma formation, whereas pulmonary tissue from PC-MW exposed 
groups do not. This was consistent with the hypothesis that PC-MW decreases toxicity compared 
to the respective AP-MW (Figure 29).  
Company 2 recognized the benefits of using MWCNT in composite material because of 
their high mechanical strength and high electrical and thermal conductivity and was prepared to 
expand their division of composite materials. However, their difficult manipulation into host 
matrices imposed enormous limitations to their use in large-scale material production. Engineers 
and polymer scientists developed, a surface treatment and functionalization protocol to improve 
dispersion and interaction of MWCNT in various matrices. This surface treatment is their 
proprietary PAE polymer coating. This coating is a non-covalent, non-wrapping approach in which 
rigid conjugated PAE polymers adhere to the surface of the MWCNT. Side chains are added to 
this backbone for enhanced compatibility, increased adhesions to host matrices, and limited 
MWCNT induced aggregation. The major interaction between the PAE backbone and nanotube 
surface creates a stabilizing energy and eases their incorporation into a large array of diverse 
matrices for downstream products.  
The toxicological evaluation of the base AP-MW was similar to previous results that 
demonstrated an increase in the inflammatory potential of MWCNT following pulmonary 
exposures in vivo (Warheit et al., 2004; Shvedova et al., 2005; Mercer et al., 2011). Qualitative 
observations of lungs exposed to the high dose AP-MW, show particle clearance, by 84 d post-
exposure. AP-MW remaining in the lung at 84 days post-exposure were present in small 
granulomas at terminal bronchioles, or within alveolar macrophages (Figure 26, 29-31). As these 
are qualitative observations, numerous studies have discussed an increase in granuloma formation 
following similar doses of MWCNT in vivo. In addition, Mercer et al. (2011) reported the frequent 
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incidence of highly loaded alveolar macrophages in MWCNT-exposed lungs, which was 
consistent with our findings (Figure 26, 29-31). 
Tabet et al. (2011) showed that a polystyrene-coated CNT was protective against 
pulmonary toxicity. In conjunction with their results, we were able to conclude that PC-MW 
induced reduced effects on cytotoxicity, inflammatory cell recruitment, and inflammatory protein 
production (Figure 22-25; 27 and 28). Enhanced darkfield imaging and qualitative assessment of 
pulmonary deposition confirmed primary particle deposition within the alveolar regions for both 
AP-MW and PC-MW exposed groups and particles persisted at 84 d post-exposure (Figure 31 and 
32). However, granuloma formation was absent in the high dose PC-MW exposed groups. In fact, 
PC-MW particles were qualitatively reported as large aggregates located at terminal bronchioles 
with minimal inflammation (Figure 29). Several mechanisms may explain these results and were 
further supported by Tabet et al. (2011). First, the coated MWCNT contained 15% polymer by 
weight and may have affected the delivered dose by altering the density of total nanotube material. 
Therefore, the lack of a granulatomas response was simply due to a reduction in total particle load 
to the lung.  Ongoing assessments are being performed to confirm that a reduction in MWCNT 
mass was not responsible for absent pathology and inflammation. Pauluhn et al. (2010) reported 
that the potential of MWCNT particles to cause reactions within the lung were dependent upon 
particle size, composition, and retained dose, which lends support to the lack of pathological 
responses in groups exposed to PC-MW. Second, perhaps the PC-MW were more hydrophobic 
than their counterpart, AP-MW, which could reduce cell adherence and explain the lack of 
inflammation surrounding large aggregates (Figure 32) (Tabet et al., 2011). A combination of these 
factors may contribute to the altered responses observed in the PC-MW exposed groups and 
ongoing studies are evaluating this phenomena. The primary aim for utilizing a proprietary PAE 
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coated MWCNT was to improve dispersion into epoxy matrices, and not necessarily reduce worker 
exposure. However, based on the results of this study, the reduction in pulmonary toxicity 
associated with PC-MW may improve the occupational safety of workers handling these coated 
tubes.  
Overall, it is clear that the proprietary PAE polymer reduced pulmonary toxicity in 
comparison to AP-MW exposed groups in vivo. Ongoing quantitative assessments are underway 
to confirm absent granuloma formation and reduced inflammation in pulmonary tissue of the PC-
MW exposed groups. Additionally, experiments are in progress to explain the underlying 
biochemical mechanism for such large particle aggregation and inflammatory response (Figure 
29).  
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8.0 General Discussion 
The main findings from this study support the hypothesis that pulmonary exposures to PC-
MW cause varying degrees of  pulmonary toxicity when compared to the base AP-MW. In neither 
instance did the polymer coating increase the toxicity of MWCNT. In fact, inflammation and 
adverse histopathology were attenuated by the PAE coating used by Company 2. There was 
remarkable consistency between PBZ collections, in vivo dosing preparations, and material 
observations in alveolar macrophages isolated from BALF (Figure 5, 12, 15, 19, 26, and 29), 
suggesting that our general toxicity finding can be reasonably extrapolated to human health 
outcomes.  
The BAL inflammatory cell and protein results detailed in this study qualitatively agree 
with other MWCNT studies. Porter et al. (2010) reported a dose response to increased 
polymorphonuclear leukocytes (PMN) following MWCNT exposures in vivo at similar doses (40 
µg). Pro-inflammatory cyotkines were increased at high dose exposures, and this was in agreement 
with previous studies involving CNT exposure (Erdely et al., 2009, 2011; Ma-Hock et al., 2013). 
However, different types polymer coatings, such as the proprietary coating (PAE) from Company 
2, appears to attenuate inflammation and developing pathology. 
 It should be noted that the PAE coating from Company 2 can have any number of  side 
chain combinations added to the backbone which makes predicting the pulmonary toxicity of other 
PAE polymer-coated MWCNT difficult. From a dosimetry perspective, the low dose caused some 
inflammation that was acute, while the high dose caused significant inflammation that resolved 
with altered histopathology. The low dose was extrapolated to represent 7.6 years and the high 
dose, 76 years, of an average exposure to workers in a U.S. facility (Erdely et al., 2013).  The first 
study of humans exposed to MWCNT, from a single facility, measured increased markers of 
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oxidative stress in enhaled breath condensates (Lee et al., 2015). These workers had a similar 
exposure compared to U.S. facilities with an average time of employment of four years. The 
general results (cytotoxicity, pulmonary inflammation) of this current study was consistent with 
past outcomes of inflammation in vivo and extrapolations to the general workforce. 
How does the polymer coating from company 2 attenuate toxicity? It was observed from 
the histopathology that this particular material, once coated, tends to form a few large 
agglomerations in the conducting airways, unlike the uncoated counterpart. These large 
agglomerates seemed to be devoid of surrounding inflammatory cells. The formation of 
agglomerates would theoretically reduce the amount taken up by macrophages. This assumption 
would be consistent with a previous study showing reduced macrophage uptake of PMMA-coated 
MWCNT (Tabot et al., 2011). The reduced uptake by macrophages and resultant lower cell 
accumulation result in the observed attenuated inflammatory response seen in both this study and 
by Tabot et al., 2013. Also, the lack of inflammatory cells surrounding the agglomerates and 
absence of granulomas, would suggest a decreased surface activity for PAE-coated MWCNT. 
Another potential contributing factor was the general appearance of reduced deposition. This is 
likely a product of the large agglomerates (difficult to know how much CNT was contained) but 
may also be a product of altered density of the coated material. Ongoing studies are looking at 
macrophage accumulation and whether the coating affected the density of the material. 
The results of this in vivo study closely related to findings of field assessment studies  of 
facilities manufacturing and handling CNT. Preparations of MWCNT that mimic workplace 
exposures are paramount for occupationally-relevant interpretations (Figure 5 and 19). Our 
nanomaterial preparation and degree of dispersion mimics PBZ measurements from exposure 
assessment studies conducted in the U.S. (Dahm et al., 2015). Most biological studies take 
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considerable measures to disperse tangled MWCNT to produce a respirable material. The question 
can be raised whether the generated material is representative of human exposures or if the 
toxicological findings are the product of a different material structure size.  To date, our research 
group is the only one to integrate exposure and toxicity assessments. This integration provides 
human health context to the toxicological outcomes. 
Despite the potential attenuation of toxicity due to some polymer coatings of MWCNT 
(this study and Tabet et al., 2011), caution should be taken in workplaces that handle large 
quantities of AP-MW and PC-MW. The scientific community relies heavily on animal models to 
evaluate results from exposures and assess their impact on the working population, as 
epidemiological studies in the past had not been conducted (Birch et al., 2011). Future 
toxicological studies involving PC-MW must incorporate extensive chemical characterizations, 
paired with in vivo and in vitro studies, in order to make predictions of their impact on human 
health (Oberdorster et al. 2016; Simeonova et al., 2009). From the results of this study and other 
toxicological evaluations in vivo, pulmonary exposures to PC-MW have the potential to induce 
significant toxicity and should not be assumed as non-toxic. 
An area of emphasis not currently addressed was the toxicologic impact of PC-MW 
following their addition into thermoplastics or composite material. Compared to composite 
material alone, these nano-enabled composites are more resistant to strain and have greater tensile 
strength (Cena et al., 2011). This study has addressed the toxicity of CNT in the first two stages 
along their life cycle from AP-MW synthesis, and post-processing (e.g. polymer coating). 
However, the next step of  manufacturing involves incorporating the PC-MW into a polymer 
matrix  (e.g. epoxy resin) and mechanically processing the PC-MW embedded composites. These 
processing steps include sanding or grinding activites, another task of manufacturing with risk of 
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inhalation exposure to particulates (Dahm et al., 2015). However, it remains unknown if the 
particulates generated as a result of sanding the PC-MW nanocomposites pose a toxicological risk 
to workers manipulating these materials. Additionally, it is unknown how different types of 
polymer coatings, like the ones addressed here, affect particulate generation. Ongoing studies are  
characterizing the aerosol generated following an industrial sanding process and complementary 
in vivo studies are addressing the toxicological impact of the respirable fraction generated from 
composites containing the PC-MW. To date, there has been no indication that free PC-MW are 
released following sanding of the composites. In support, previous studies that processed CNT-
nanocomposites reported that respirable sized particles are generated but generally lack the 
presence of free nanoparticles (Cena et al., 2011). Also, it was concluded the probability of adverse 
health effects due to the inhalation of free PC-MW from sanded particulates generated from 
composites remains extremely low (Wohlleben et al., 2011). To date, no studies have shown 
enhanced toxicity from particulates collected from CNT-enabled composites compared to particles 
collected from the base composite with no CNT added. 
The issue of health and wellness is not new to manufacturers of engineered nanomaterials, 
many of whom, have introduced engineering controls to reduce worker exposure. There are tasks 
within any workforce where individuals face a host of challenges that could result in reduced 
stamina, flexibility and strength. Considering all the variables to maintain optimal worker health, 
the easiest to control is exposure by preventative measures such as ventilation, filtration and 
enclosure. By understanding the toxicity of CNT along their life cycle, from AP-MW to PC-MW, 
companies like evaluated here, can use this information to establish protocols that reduce worker 
exposure and toxicity, while continuing to make advancements in nano-enabled products.  
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